Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals
Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals
Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals
Submitted by
admin
on August 20, 2010 - 12:51pm
Source:
BNET Pharma
News Tags:
Elan
SEC
epilepsy
lorazepam
Amarin
Headline:
Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals
Do Not Allow Advertisers to Use My Personal information
